Autolus Therapeutics PLC
NASDAQ:AUTL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.13
7.29
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Autolus Therapeutics PLC
Wall Street
Price Targets
AUTL Price Targets Summary
Autolus Therapeutics PLC
According to Wall Street analysts, the average 1-year price target for
AUTL
is 10.61 USD
with a low forecast of 7.07 USD and a high forecast of 13.65 USD.
AUTL Last Price Targets
Autolus Therapeutics PLC
The latest public price target was made on May 20, 2024 by
Yanan Zhu
from
Wells Fargo
,
who expects
AUTL
stock to
rise by 108%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Yanan Zhu
Wells Fargo
|
8
USD
Upside 108% |
4 months ago
May 20, 2024
|
Wells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL)
StreetInsider
|
Asthika Goonewardene
Truist Financial
|
11
USD
Upside 186% |
5 months ago
Apr 8, 2024
|
Autolus Therapeutics plc (AUTL) PT Raised to $11 at Truist Securities
StreetInsider
|
|
Asthika Goonewardene
Truist Financial
|
10
USD
Upside 160% |
6 months ago
Mar 15, 2024
|
Autolus Therapeutics plc (AUTL) PT Raised to $10 at Truist Securities
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AUTL's stock price target?
Price Target
10.61
USD
According to Wall Street analysts, the average 1-year price target for
AUTL
is 10.61 USD
with a low forecast of 7.07 USD and a high forecast of 13.65 USD.
What is Autolus Therapeutics PLC's Revenue forecast?
Projected CAGR
351%
For the last 6 years the
compound annual growth rate for
Autolus Therapeutics PLC's revenue is
0%.
The projected
CAGR
for the next 3 years is
351%.
You don't have any saved screeners yet
